Oral Semaglutide + Basal Insulin

Categorieën: Gezondheid | Welzijn Gezondheid Opvoeding Leeftijd: 14 t/m 18 jaar 19 t/m 30 jaar 31 t/m 64 jaar

Laden...

4 jaren geleden

Html
Tekst

Plus: depression app; DIY artificial pancreas; childhood height & diabetes risk

July 18, 2020 : Issue #1051

TOP STORIES - Diabetes News & Research

Oral Semaglutide + Basal Insulin
Do-It-Yourself Artificial Pancreas for Type 1 Patients
Technology’s Evolving Role in Depression

Letter from the Editor
This week our FAMU intern Brianna Belton has a great feature on the use of a new medical app to help track and treat depression. The app looks at steps and text messaging to determine depression levels. I am reminded of Aaron Burr’s line from the hit show Hamilton: “Depress less; walk more." Well, that was not exactly what he said, but if Lin-Manuel Miranda can take some poetic liberty then so can I.
I may have been reminded of that phrase while I was reading the feature and saw the mention that results were based in part on the HAM-A (Hamilton Anxiety Rating Scale). This app may turn out to be a great one to use as more of our patients are having problems with anxiety and depression, and the opportunity to see a mental health professional is decreased.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief

Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option

Did You Know? Taller Children May Have Increased Risk for Type 2:

Taller children are more likely to have a higher body mass index than shorter children, which can increase the risk for T2D, according to a study done on children between 2 and 13.8 years of age. Several cross‐sectional studies have shown that height in childhood is correlated with BMI and with body fatness, and two longitudinal studies have reported that childhood height is associated with adult BMI. This study, published (July 2020) in the journal Obesity, explored this longitudinal association in an electronic health record database of 2.8 million children.
The researchers concluded that children who are relatively tall for their age have a higher risk of developing obesity and eventually a higher risk for diabetes. When they were re-examined, an average of 4 years later (but up to 13 years later), it was found that taller children were more likely to have a higher body mass index than shorter children. For example, among the thinnest children at the start, the prevalence of obesity at the second exam was 5-fold higher in the tallest children than in the shortest children (3.1 percent versus 0.6 percent). Among the heaviest children at the start, the respective prevalence rates of obesity were 89.5 percent versus 53.4 percent. According to the lead author David S Freedman, Ph.D., of the Centers for Disease Control and Prevention, "Height may be a simple way to classify which children will become obese accurately."
Obesity, July 2020

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Brianna Belton, PharmD. Candidate, Florida Agricultural & Mechanical University, College of Pharmacy and Pharmaceutical Sciences

Lawand Kamal, PharmD Candidate 2021, Skaggs School of Pharmacy and Pharmaceutical Sciences

Sameen Khan, Pharm.D. Candidate, USF College of Pharmacy

Maya Palmer, PharmD. Candidate, Florida A&M University College of Pharmacy

Stephen Rubano, PharmD. Candidate, USF Taneja College of Pharmacy

About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.

Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com

©2020 HIPER, LLC. All rights reserved.
This email was sent by eHealthcare Solutions on behalf of: Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States
DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe